Antidepressant study probes anger processing in healthy youth
NCT ID NCT07424781
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study at the University of Oxford is testing how the antidepressant fluoxetine (Prozac) influences the way healthy young people process anger. Eighty participants aged 18-24 will take either fluoxetine or a placebo for 7 days and complete tasks involving angry faces, words, and frustrating situations. Researchers will also measure heart rate and facial expressions to understand the drug's effects on anger-related responses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fluoxetine
- What this could lead to
- If it works, this could help explain how antidepressants influence emotional responses, potentially improving treatment for depression and irritability.
- What could go wrong
- This is a small, early-stage study in healthy volunteers, not patients. Results may not apply to people with depression, and the short 7-day treatment may not reflect real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Psychiatry, University of Oxford
RECRUITINGOxford, Oxfordshire, OX3 7JX, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a new drug offer hope for Treatment-Resistant depression?
- What did COVID-19 mean for family caregivers in zambia? a study seeks answers